National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA 01702-5803, USA.
Circulation. 2011 Jul 5;124(1):24-30. doi: 10.1161/CIRCULATIONAHA.110.979203. Epub 2011 Jun 13.
Heart failure (HF) is a clinical syndrome characterized by signs and symptoms involving multiple organ systems. Longitudinal data demonstrating that asymptomatic cardiac dysfunction precedes overt HF are scarce, and the contribution of noncardiac dysfunction to HF progression is unclear. We hypothesized that subclinical cardiac and noncardiac organ dysfunction would accelerate the manifestation of HF.
We studied 1038 participants of the Framingham Heart Study original cohort (mean age, 76±5 years; 39% men) with routine assessment of left ventricular systolic and diastolic function. Major noncardiac organ systems were assessed with the use of serum creatinine (renal), serum albumin (hepatic), ratio of forced expiratory volume in 1 second to forced vital capacity (FEV(1):FVC ratio; pulmonary), hemoglobin concentration (hematologic/oxygen-carrying capacity), and white blood cell count (systemic inflammation). On follow-up (mean, 11 years), there were 248 incident HF events (146 in women). After adjustment for established HF risk factors, antecedent left ventricular systolic dysfunction (hazard ratio, 2.33; 95% confidence interval, 1.43 to 3.78) and diastolic dysfunction (hazard ratio, 1.32; 95% confidence interval, 1.01 to 1.71) were associated with increased HF risk. After adjustment for cardiac dysfunction, higher serum creatinine, lower FEV1:FVC ratios, and lower hemoglobin concentrations were associated with increased HF risk (all P<0.05); serum albumin and white blood cell count were not. Subclinical dysfunction in each noncardiac organ system was associated with a 30% increased risk of HF (P=0.013).
Antecedent cardiac dysfunction and noncardiac organ dysfunction are associated with increased incidence of HF, supporting the notion that HF is a progressive syndrome and underscoring the importance of noncardiac factors in its occurrence.
心力衰竭(HF)是一种以涉及多个器官系统的体征和症状为特征的临床综合征。有少量的纵向数据表明无症状性心功能障碍先于明显的 HF,但非心功能障碍对 HF 进展的贡献尚不清楚。我们假设亚临床心脏和非心脏器官功能障碍会加速 HF 的发生。
我们研究了弗雷明汉心脏研究原始队列的 1038 名参与者(平均年龄 76±5 岁,39%为男性),常规评估左心室收缩和舒张功能。主要非心脏器官系统通过血清肌酐(肾脏)、血清白蛋白(肝脏)、1 秒用力呼气量与用力肺活量比值(FEV1:FVC 比值;肺部)、血红蛋白浓度(血液携氧能力)和白细胞计数(全身炎症)进行评估。随访(平均 11 年)期间,发生了 248 例 HF 事件(女性 146 例)。在调整了 HF 的既定危险因素后,先前的左心室收缩功能障碍(危险比 2.33;95%置信区间 1.43 至 3.78)和舒张功能障碍(危险比 1.32;95%置信区间 1.01 至 1.71)与 HF 风险增加相关。在调整了心脏功能障碍后,较高的血清肌酐、较低的 FEV1:FVC 比值和较低的血红蛋白浓度与 HF 风险增加相关(均 P<0.05);血清白蛋白和白细胞计数则不然。每个非心脏器官系统的亚临床功能障碍与 HF 风险增加 30%相关(P=0.013)。
先前的心脏功能障碍和非心脏器官功能障碍与 HF 的发生率增加相关,这支持了 HF 是一种进行性综合征的观点,并强调了非心脏因素在其发生中的重要性。